BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31079220)

  • 1. The role of thioredoxin system in cancer: strategy for cancer therapy.
    Jia JJ; Geng WS; Wang ZQ; Chen L; Zeng XS
    Cancer Chemother Pharmacol; 2019 Sep; 84(3):453-470. PubMed ID: 31079220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Thioredoxin System for Cancer Therapy.
    Zhang J; Li X; Han X; Liu R; Fang J
    Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF; Di Trapani G
    Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Thioredoxin System as a Strategy for Cancer Therapy.
    Bian M; Fan R; Zhao S; Liu W
    J Med Chem; 2019 Aug; 62(16):7309-7321. PubMed ID: 30963763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thioredoxin system and cancer therapy: a review.
    Mohammadi F; Soltani A; Ghahremanloo A; Javid H; Hashemy SI
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):925-935. PubMed ID: 31367788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the Functions of Thioredoxin System in Central Nervous System Diseases.
    Jia J; Xu G; Zhu D; Liu H; Zeng X; Li L
    Antioxid Redox Signal; 2023 Feb; 38(4-6):425-441. PubMed ID: 35761787
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
    Liu Y; Li Y; Yu S; Zhao G
    Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.
    Yao A; Storr SJ; Al-Hadyan K; Rahman R; Smith S; Grundy R; Paine S; Martin SG
    Mol Neurobiol; 2020 Jul; 57(7):2889-2901. PubMed ID: 32418115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid Upregulates Thioredoxin-interacting Protein in Cultured Neuronal Cells.
    Bharti V; Tan H; Chow D; Wang Y; Nagakannan P; Eftekharpour E; Wang JF
    Neuroscience; 2018 Aug; 384():375-383. PubMed ID: 29894818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin system in cell death progression.
    Lu J; Holmgren A
    Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems.
    Schmitz AE; de Souza LF; Dos Santos B; Maher P; Lopes FM; Londero GF; Klamt F; Dafre AL
    Neurotox Res; 2017 Oct; 32(3):340-350. PubMed ID: 28478530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin system modulation by plant and fungal secondary metabolites.
    Dal Piaz F; Braca A; Belisario MA; De Tommasi N
    Curr Med Chem; 2010; 17(5):479-94. PubMed ID: 19941471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
    Chong CR; Chan WP; Nguyen TH; Liu S; Procter NE; Ngo DT; Sverdlov AL; Chirkov YY; Horowitz JD
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):347-60. PubMed ID: 25088927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiol-Based Antioxidants and the Epithelial/Mesenchymal Transition in Cancer.
    Ogata FT; Simões Sato AY; Coppo L; Arai RJ; Stern AI; Pequeno Monteiro H
    Antioxid Redox Signal; 2022 May; 36(13-15):1037-1050. PubMed ID: 34541904
    [No Abstract]   [Full Text] [Related]  

  • 16. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
    Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
    Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thioredoxin system as a therapeutic target in human health and disease.
    Mahmood DF; Abderrazak A; El Hadri K; Simmet T; Rouis M
    Antioxid Redox Signal; 2013 Oct; 19(11):1266-303. PubMed ID: 23244617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J; Xu J; Tian L; Zhong L
    Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and distribution of thioredoxin and thioredoxin reductase in human nasal mucosa and nasal polyp.
    Lee SH; Kim WS; Lee SH; Oh JW; Lee HM; Jung HH; Jang JW; Jun YJ; Cho WJ; Jhun HS
    Acta Otolaryngol; 2005 Aug; 125(8):877-82. PubMed ID: 16158536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thioredoxin system in cancer.
    Arnér ES; Holmgren A
    Semin Cancer Biol; 2006 Dec; 16(6):420-6. PubMed ID: 17092741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.